DOCSLIB.ORG

Roles of Ubiquitination and Sumoylation in the Regulation of Angiogenesis

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Roles of Ubiquitination and Sumoylation in the Regulation of Angiogenesis Curr. Issues Mol. Biol. (2020) 35: 109-126. Roles of Ubiquitination and SUMOylation in the Regulation of Angiogenesis Andrea Rabellino1*, Cristina Andreani2 and Pier Paolo Scaglioni2 1QIMR Berghofer Medical Research Institute, Brisbane City, Queensland, Australia. 2Department of Internal Medicine, Hematology and Oncology; University of Cincinnati, Cincinnati, OH, USA. *Correspondence: [email protected] htps://doi.org/10.21775/cimb.035.109 Abstract is tumorigenesis-induced angiogenesis, during Te generation of new blood vessels from the which hypoxic and starved cancer cells activate existing vasculature is a dynamic and complex the molecular pathways involved in the formation mechanism known as angiogenesis. Angiogenesis of novel blood vessels, in order to supply nutri- occurs during the entire lifespan of vertebrates and ents and oxygen required for the tumour growth. participates in many physiological processes. Fur- Additionally, more than 70 diferent disorders have thermore, angiogenesis is also actively involved been associated to de novo angiogenesis including in many human diseases and disorders, including obesity, bacterial infections and AIDS (Carmeliet, cancer, obesity and infections. Several inter-con- 2003). nected molecular pathways regulate angiogenesis, At the molecular level, angiogenesis relays on and post-translational modifcations, such as phos- several pathways that cooperate in order to regulate phorylation, ubiquitination and SUMOylation, in a precise spatial and temporal order the process. tightly regulate these mechanisms and play a key In this context, post-translational modifcations role in the control of the process. Here, we describe (PTMs) play a central role in the regulation of these in detail the roles of ubiquitination and SUMOyla- events, infuencing the activation and stability of tion in the regulation of angiogenesis. many growth factors, membrane receptors and downstream signalling efector molecules. Here, we will focus on the role of ubiquitination and Introduction SUMOylation in the regulation of angiogenesis. Te growth of new blood vessels from the exist- ing vasculature is a process known as angiogenesis (Carmeliet, 2003; Ucuzian et al., 2010). In ver- Molecular basics of tebrates, angiogenesis occurs across the entire angiogenesis lifespan and participates in multiple physiological Blood vessels arise from endothelial precursor processes, such as pregnancy, embryonic develop- cells, in a process known as vasculogenesis. Further ment and wound healing. Moreover, many diseases stabilization of the new blood vessels, including can promote de novo angiogenesis, a process also their expansive growth and the formation of known as pathological angiogenesis or neo- collateral bridges is known as angiogenesis (Car- angiogenesis. In this regard, a well-known example meliet, 2003). During angiogenesis, a dynamic caister.com/cimb 109 Curr. Issues Mol. Biol. Vol. 35 314 | Rabellino et al. and complex crosstalk occurs between endothe- can regulate cell migration in response to VEGF. lial cells and the extracellular matrix in a tightly On the other hand, anti-angiogenic factors such as regulated manner in order to promote endothelial the Endostatins are potent inhibitors of endothelial cells proliferation and diferentiation, cytoskeletal cells migration counteracting the formation of focal reorganization and cell migration, and the forma- adhesions (Dixelius et al., 2003; Eriksson et al., tion of novel vessels (Carmeliet, 2003; Huang and 2003). Bao, 2004; Muñoz-Chápuli et al., 2004; Ucuzian et Typically, during endothelial cell migration, al., 2010). Endothelial cells, fbroblasts, platelets, cell proliferation is enhanced, while apoptosis is infammatory cells and cancer cells (Ucuzian et repressed. Generally, the apoptotic signals that al., 2010) can all act as sources of angiogenic fac- regulate angiogenesis and the fate of endothelial tors. Key pro-angiogenic factors are the Vascular cells are mediated by TNF-α and TGF-β signalling Endothelial Growth Factors (VEGF1–5) and their (Polunovsky et al., 1994; Choi and Ballermann, receptors (VEGFR1, VEGFR2 and VEGFR3), the 1995). During angiogenesis, however, apoptotic Placental Growth Factors (PlGFs), the Fibroblast pathways are inhibited by the crosstalk between Growth Factors (FGF1 and FGF2) and FGF Integrins, VEGF and FGF cascades that converge receptors (FGFR1–4), the Transforming Growth toward the activation of the AKT pathway (Gerber Factor (TGF-β) family, the Tumour Necrosis et al., 1998). Other signalling pathways involved in Factor (TNF-α), the family of the Angiopoietins angiogenesis include WNT signalling (Dufourcq et (ANG1 and ANG2) and the TIE-1 and -2 recep- al., 2002), and the pathways activated by cytokines, tors, Ephrins and Leptins (Carmeliet, 2003; Huang such as Pleiotrophin and Midkine (Stoica et al., and Bao, 2004; Ucuzian et al., 2010). On the 2001, 2002), and oestrogens (Hyder et al., 1996). other hand, anti-angiogenic factors include the Because hypoxia is an important factor in angio- Trombospondins (TSP1–4 and TSP-5/COMP), genesis, also Hypoxia-Inducible Factors (HIFs) Angiostatins and Endostatins (Huang and Bao, play a fundamental role in neo-angiogenesis during 2004). Moreover, other players may diferentially tumour development (Pugh and Ratclife, 2003). contribute to the control of angiogenesis, like the HIF is a basic helix–loop–helix heterodimeric Matrix Metalloproteinases (MMPs), Integrins, and transcription factor that under hypoxic condition the extracellular matrix (ECM) (Kessenbrock et al., binds to hypoxic response elements (HREs) of 2010). Tese factors activate several downstream the DNA inducing the transcription of a series of signalling pathways. For example, VEGF, and hypoxia-related genes, many of which are involved similarly FGF, mainly activate the ERK/MAPK in angiogenesis (Semenza, 2000; Wenger, 2002). pathway (Larsson et al., 1999; Cross et al., 2000; Wu For example, VEGF transcription is directly up- et al., 2000), leading to the transcription of master regulated by HIF activity in hypoxic conditions genes involved in cell proliferation, such as MYC, (Levy et al., 1998; Pugh and Ratclife, 2003; Zhang ELK-1, FOS, etc. (Muñoz-Chápuli et al., 2004). On et al., 2012; De Francesco et al., 2013). Accordingly, the other end, VEGF can also act independently of Hif-1α knock out mice show abnormal vascular the ERK/MAPK cascade by activating other path- development and embryonic lethality (Maltepe et ways such as the STAT signalling (Muñoz-Chápuli al., 1997; Kotch et al., 1999). et al., 2004). Interestingly, additional stimuli can cooperate with angiogenic factors. Accordingly, Nitric Oxide (NO) is able to potentiate the VEGF- PTMs in angiogenesis dependent activation of the angiogenic pathways PTMs are a series of covalent modifcations that (Donnini and Ziche, 2002). VEGF also directly occur following protein synthesis, and regulate controls the migration of endothelial cells during protein activity, turnover and/or localization. Te angiogenesis activating the RHO GTPases RHO most common PTMs include phosphorylation, and RC, which are required for cell motility acetylation, glycosylation, ubiquitination and and the formation of focal adhesions (Soga et al., SUMOylation. Every PTM is strictly regulated 2001a,b). Moreover, other factors, such as the by several molecular mechanisms and feedback Protein Kinase C (PKC) (Yamamura et al., 1996), loops. Interestingly, every single PTM described or the receptor NOTCH (Hellström et al., 2007), so far participates in the regulation and control caister.com/cimb 110 Curr. Issues Mol. Biol. Vol. 35 Ubiquitin and SUMO in Angiogenesis | 315 of angiogenesis (Rahimi and Costello, 2015). In so far, including RanBP2, PC2, TOPORS and the this review, we will focus on ubiquitination and PIAS family (Rabellino et al., 2017). SUMOylation, and will describe how these PTMs Both ubiquitination and SUMOylation start work and impact angiogenesis. with the atachment of a single Ub or SUMO to the target protein: these mono-ubiquitination/ SUMOylation events have several repercussions Ubiquitination and SUMOylation on the fate of the target. Moreover, both Ub and in angiogenesis SUMO ofen form complex branched chains, and Ubiquitination and SUMOylation are PTMs the complexity and/or the length of the chains that regulate the activity and fate of a plethora will determine the fate of the modifed-target. For of proteins (Clague et al., 2015; Hendriks et al., example, Ub contains seven K residues that can be 2015). Both ubiquitination and SUMOylation ubiquitinated, thus participating to the formation consist of the covalent binding of a small protein of complex and branched Ub chains (Kim et al., modifer (ubiquitin, Ub hereafer, or Small 2011; Wagner et al., 2011). Ubiquitin-like Modifer, SUMO hereafer) to one Owing to the presence of multiple SUMO paral- or multiple lysine (K) residues of a target protein. ogs, the SUMOylation machinery is more complex Both processes require three consecutive steps than ubiquitination. In vertebrates, fve diferent (Fig. 18.1), sequentially catalysed by E1, E2 and SUMO genes exist and they encode for 5 diferent E3 ligases (Swatek and Komander, 2016; Rabellino SUMO proteins (SUMO1–5): SUMO1, SUMO2 et al., 2017). While for ubiquitination, a variety of and SUMO3 are ubiquitously expressed, while E1–3 ligases are known, for SUMOylation, only one SUMO4 and SUMO5 are tissue specifc and not E1 (SAE1/2) and one E2 (UBC9) are known, and well characterized
Load more

Recommended publications
  • Isoform-Specific Monobody Inhibitors of Small Ubiquitin-Related Modifiers Engineered Using Structure-Guided Library Design
    Isoform-specific monobody inhibitors of small ubiquitin-related modifiers engineered using structure-guided library design Ryan N. Gilbretha, Khue Truongb, Ikenna Madub, Akiko Koidea, John B. Wojcika, Nan-Sheng Lia, Joseph A. Piccirillia,c, Yuan Chenb, and Shohei Koidea,1 aDepartment of Biochemistry and Molecular Biology, and cDepartment of Chemistry, University of Chicago, 929 East 57th Street, Chicago, IL 60637; and bDepartment of Molecular Medicine, Beckman Research Institute of the City of Hope, 1450 East Duarte Road, Duarte, CA 91010 Edited by David Baker, University of Washington, Seattle, WA, and approved March 16, 2011 (received for review February 10, 2011) Discriminating closely related molecules remains a major challenge which SUMOylation alters protein function appears to be in the engineering of binding proteins and inhibitors. Here we through SUMO-mediated interactions with other proteins con- report the development of highly selective inhibitors of small ubi- taining a short peptide motif known as a SUMO-interacting motif quitin-related modifier (SUMO) family proteins. SUMOylation is (SIM) (4, 7, 8). involved in the regulation of diverse cellular processes. Functional There are few inhibitors of SUMO/SIM interactions, a defi- differences between two major SUMO isoforms in humans, SUMO1 ciency that limits our ability to finely dissect SUMO biology. In and SUMO2∕3, are thought to arise from distinct interactions the only reported example of such an inhibitor, a SIM-containing mediated by each isoform with other proteins containing SUMO- linear peptide was used to inhibit SUMO/SIM interactions, estab- interacting motifs (SIMs). However, the roles of such isoform- lishing their importance in coordinating DNA repair by nonho- specific interactions are largely uncharacterized due in part to the mologous end joining (9).
    [Show full text]
  • Recruitment of Ubiquitin-Activating Enzyme UBA1 to DNA by Poly(ADP-Ribose) Promotes ATR Signalling
    Published Online: 21 June, 2018 | Supp Info: http://doi.org/10.26508/lsa.201800096 Downloaded from life-science-alliance.org on 1 October, 2021 Research Article Recruitment of ubiquitin-activating enzyme UBA1 to DNA by poly(ADP-ribose) promotes ATR signalling Ramhari Kumbhar1, Sophie Vidal-Eychenie´ 1, Dimitrios-Georgios Kontopoulos2 , Marion Larroque3, Christian Larroque4, Jihane Basbous1,Sofia Kossida1,5, Cyril Ribeyre1 , Angelos Constantinou1 The DNA damage response (DDR) ensures cellular adaptation to Saldivar et al, 2017). Induction of the DDR triggers a cascade of genotoxic insults. In the crowded environment of the nucleus, the protein modifications by ADP-ribosylation, phosphorylation, SUMOylation, assembly of productive DDR complexes requires multiple protein ubiquitylation, acetylation, and methylation, which collectively modifications. How the apical E1 ubiquitin activation enzyme promote the assembly of DNA damage signalling and DNA repair UBA1 integrates spatially and temporally in the DDR remains proteins into discrete chromatin foci (Ciccia & Elledge, 2010; elusive. Using a human cell-free system, we show that poly(ADP- Dantuma & van Attikum, 2016). ribose) polymerase 1 promotes the recruitment of UBA1 to DNA. One of the earliest responses to DNA damage is the conjugation We find that the association of UBA1 with poly(ADP-ribosyl)ated by PARP1 of pADPr to substrate proteins, including itself, at DNA protein–DNA complexes is necessary for the phosphorylation rep- breaks and stalled replication forks (Caldecott et al, 1996; Bryant lication protein A and checkpoint kinase 1 by the serine/threonine et al, 2009; Langelier et al, 2011). PARP1 activity is induced by dis- protein kinase ataxia-telangiectasia and RAD3-related, a prototypal continuous DNA structures such as nicks, DSBs, and DNA cruciform response to DNA damage.
    [Show full text]
  • HSF-1 Activates the Ubiquitin Proteasome System to Promote Non-Apoptotic
    HSF-1 Activates the Ubiquitin Proteasome System to Promote Non-Apoptotic Developmental Cell Death in C. elegans Maxime J. Kinet#, Jennifer A. Malin#, Mary C. Abraham, Elyse S. Blum, Melanie Silverman, Yun Lu, and Shai Shaham* Laboratory of Developmental Genetics The Rockefeller University 1230 York Avenue New York, NY 10065 USA #These authors contributed equally to this work *To whom correspondence should be addressed: Tel (212) 327-7126, Fax (212) 327- 7129, email [email protected] Kinet, Malin et al. Abstract Apoptosis is a prominent metazoan cell death form. Yet, mutations in apoptosis regulators cause only minor defects in vertebrate development, suggesting that another developmental cell death mechanism exists. While some non-apoptotic programs have been molecularly characterized, none appear to control developmental cell culling. Linker-cell-type death (LCD) is a morphologically conserved non-apoptotic cell death process operating in C. elegans and vertebrate development, and is therefore a compelling candidate process complementing apoptosis. However, the details of LCD execution are not known. Here we delineate a molecular-genetic pathway governing LCD in C. elegans. Redundant activities of antagonistic Wnt signals, a temporal control pathway, and MAPKK signaling control HSF-1, a conserved stress-activated transcription factor. Rather than protecting cells, HSF-1 promotes their demise by activating components of the ubiquitin proteasome system, including the E2 ligase LET- 70/UBE2D2 functioning with E3 components CUL-3, RBX-1, BTBD-2, and SIAH-1. Our studies uncover design similarities between LCD and developmental apoptosis, and provide testable predictions for analyzing LCD in vertebrates. 2 Kinet, Malin et al. Introduction Animal development and homeostasis are carefully tuned to balance cell proliferation and death.
    [Show full text]
  • BC-Box Protein Domain-Related Mechanism for VHL Protein Degradation
    BC-box protein domain-related mechanism for VHL protein degradation Maria Elena Pozzebona,1,2, Archana Varadaraja,1, Domenico Mattoscioa, Ellis G. Jaffrayb, Claudia Miccoloa, Viviana Galimbertic, Massimo Tommasinod, Ronald T. Hayb, and Susanna Chioccaa,3 aDepartment of Experimental Oncology, European Institute of Oncology, 20139 Milan, Italy; cSenology Division, European Institute of Oncology, 20141 Milan, Italy; dInternational Agency for Research on Cancer, World Health Organization, 69372 Lyon, France; and bCentre for Gene Regulation and Expression, University of Dundee, Dundee DD1 5EH, United Kingdom Edited by William G. Kaelin, Jr., Harvard Medical School, Boston, MA, and approved September 23, 2013 (received for review June 18, 2013) The tumor suppressor VHL (von Hippel–Lindau) protein is a sub- effects of the wild-type Gam1 protein (18, 20, 21), supporting the strate receptor for Ubiquitin Cullin Ring Ligase complexes (CRLs), idea that these effects may depend on Gam1 ability to act as containing a BC-box domain that associates to the adaptor Elongin substrate-receptor protein. B/C. VHL targets hypoxia-inducible factor 1α to proteasome- VHL (von Hippel–Lindau) protein is a cellular BC box-con- dependent degradation. Gam1 is an adenoviral protein, which also taining substrate receptor and associates with Cullin2-based E3 possesses a BC-box domain that interacts with the host Elongin B/C, ligases (22–24). VHL is a tumor suppressor, and its loss leads to – thereby acting as a viral substrate receptor. Gam1 associates with the von Hippel Lindau syndrome that often develops into renal both Cullin2 and Cullin5 to form CRL complexes targeting the host clear-cell carcinoma and other highly vascularized tumors (25, 26).
    [Show full text]
  • Supplementary Table S5. Differentially Expressed Gene Lists of PD-1High CD39+ CD8 Tils According to 4-1BB Expression Compared to PD-1+ CD39- CD8 Tils
    BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance Supplemental material placed on this supplemental material which has been supplied by the author(s) J Immunother Cancer Supplementary Table S5. Differentially expressed gene lists of PD-1high CD39+ CD8 TILs according to 4-1BB expression compared to PD-1+ CD39- CD8 TILs Up- or down- regulated genes in Up- or down- regulated genes Up- or down- regulated genes only PD-1high CD39+ CD8 TILs only in 4-1BBneg PD-1high CD39+ in 4-1BBpos PD-1high CD39+ CD8 compared to PD-1+ CD39- CD8 CD8 TILs compared to PD-1+ TILs compared to PD-1+ CD39- TILs CD39- CD8 TILs CD8 TILs IL7R KLRG1 TNFSF4 ENTPD1 DHRS3 LEF1 ITGA5 MKI67 PZP KLF3 RYR2 SIK1B ANK3 LYST PPP1R3B ETV1 ADAM28 H2AC13 CCR7 GFOD1 RASGRP2 ITGAX MAST4 RAD51AP1 MYO1E CLCF1 NEBL S1PR5 VCL MPP7 MS4A6A PHLDB1 GFPT2 TNF RPL3 SPRY4 VCAM1 B4GALT5 TIPARP TNS3 PDCD1 POLQ AKAP5 IL6ST LY9 PLXND1 PLEKHA1 NEU1 DGKH SPRY2 PLEKHG3 IKZF4 MTX3 PARK7 ATP8B4 SYT11 PTGER4 SORL1 RAB11FIP5 BRCA1 MAP4K3 NCR1 CCR4 S1PR1 PDE8A IFIT2 EPHA4 ARHGEF12 PAICS PELI2 LAT2 GPRASP1 TTN RPLP0 IL4I1 AUTS2 RPS3 CDCA3 NHS LONRF2 CDC42EP3 SLCO3A1 RRM2 ADAMTSL4 INPP5F ARHGAP31 ESCO2 ADRB2 CSF1 WDHD1 GOLIM4 CDK5RAP1 CD69 GLUL HJURP SHC4 GNLY TTC9 HELLS DPP4 IL23A PITPNC1 TOX ARHGEF9 EXO1 SLC4A4 CKAP4 CARMIL3 NHSL2 DZIP3 GINS1 FUT8 UBASH3B CDCA5 PDE7B SOGA1 CDC45 NR3C2 TRIB1 KIF14 TRAF5 LIMS1 PPP1R2C TNFRSF9 KLRC2 POLA1 CD80 ATP10D CDCA8 SETD7 IER2 PATL2 CCDC141 CD84 HSPA6 CYB561 MPHOSPH9 CLSPN KLRC1 PTMS SCML4 ZBTB10 CCL3 CA5B PIP5K1B WNT9A CCNH GEM IL18RAP GGH SARDH B3GNT7 C13orf46 SBF2 IKZF3 ZMAT1 TCF7 NECTIN1 H3C7 FOS PAG1 HECA SLC4A10 SLC35G2 PER1 P2RY1 NFKBIA WDR76 PLAUR KDM1A H1-5 TSHZ2 FAM102B HMMR GPR132 CCRL2 PARP8 A2M ST8SIA1 NUF2 IL5RA RBPMS UBE2T USP53 EEF1A1 PLAC8 LGR6 TMEM123 NEK2 SNAP47 PTGIS SH2B3 P2RY8 S100PBP PLEKHA7 CLNK CRIM1 MGAT5 YBX3 TP53INP1 DTL CFH FEZ1 MYB FRMD4B TSPAN5 STIL ITGA2 GOLGA6L10 MYBL2 AHI1 CAND2 GZMB RBPJ PELI1 HSPA1B KCNK5 GOLGA6L9 TICRR TPRG1 UBE2C AURKA Leem G, et al.
    [Show full text]
  • Serum Albumin OS=Homo Sapiens
    Protein Name Cluster of Glial fibrillary acidic protein OS=Homo sapiens GN=GFAP PE=1 SV=1 (P14136) Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 Cluster of Isoform 3 of Plectin OS=Homo sapiens GN=PLEC (Q15149-3) Cluster of Hemoglobin subunit beta OS=Homo sapiens GN=HBB PE=1 SV=2 (P68871) Vimentin OS=Homo sapiens GN=VIM PE=1 SV=4 Cluster of Tubulin beta-3 chain OS=Homo sapiens GN=TUBB3 PE=1 SV=2 (Q13509) Cluster of Actin, cytoplasmic 1 OS=Homo sapiens GN=ACTB PE=1 SV=1 (P60709) Cluster of Tubulin alpha-1B chain OS=Homo sapiens GN=TUBA1B PE=1 SV=1 (P68363) Cluster of Isoform 2 of Spectrin alpha chain, non-erythrocytic 1 OS=Homo sapiens GN=SPTAN1 (Q13813-2) Hemoglobin subunit alpha OS=Homo sapiens GN=HBA1 PE=1 SV=2 Cluster of Spectrin beta chain, non-erythrocytic 1 OS=Homo sapiens GN=SPTBN1 PE=1 SV=2 (Q01082) Cluster of Pyruvate kinase isozymes M1/M2 OS=Homo sapiens GN=PKM PE=1 SV=4 (P14618) Glyceraldehyde-3-phosphate dehydrogenase OS=Homo sapiens GN=GAPDH PE=1 SV=3 Clathrin heavy chain 1 OS=Homo sapiens GN=CLTC PE=1 SV=5 Filamin-A OS=Homo sapiens GN=FLNA PE=1 SV=4 Cytoplasmic dynein 1 heavy chain 1 OS=Homo sapiens GN=DYNC1H1 PE=1 SV=5 Cluster of ATPase, Na+/K+ transporting, alpha 2 (+) polypeptide OS=Homo sapiens GN=ATP1A2 PE=3 SV=1 (B1AKY9) Fibrinogen beta chain OS=Homo sapiens GN=FGB PE=1 SV=2 Fibrinogen alpha chain OS=Homo sapiens GN=FGA PE=1 SV=2 Dihydropyrimidinase-related protein 2 OS=Homo sapiens GN=DPYSL2 PE=1 SV=1 Cluster of Alpha-actinin-1 OS=Homo sapiens GN=ACTN1 PE=1 SV=2 (P12814) 60 kDa heat shock protein, mitochondrial OS=Homo
    [Show full text]
  • UBA1 (UBE1), Active Recombinant Full-Length Human Proteins Expressed in Sf9 Cells
    Catalog # Aliquot Size U201-380G-20 20 µg U201-380G-50 50 µg UBA1 (UBE1), Active Recombinant full-length human proteins expressed in Sf9 cells Catalog # U201-380G Lot # V2408-6 Product Description Specific Activity Full-length recombinant human UBA1 was expressed by baculovirus in Sf9 insect cells using an N-terminal GST tag. 2,800,000 The UBA1 gene accession number is NM_003334. 2,100,000 Gene Aliases 1,400,000 UBE1, CTD-2522E6.1, A1S9, A1S9T, A1ST, AMCX1, GXP1, 700,000 POC20, SMAX2, UBA1A, UBE1X Activity (RLU) 0 Formulation 0 20 40 60 80 Protein (ng) Recombinant proteins stored in 50mM Tris-HCl, pH 7.5, 150mM NaCl, 10mM glutathione, 0.1mM EDTA, 0.25mM The specific activity of UBA1 was determined to be 110 nmol DTT, 0.1mM PMSF, 25% glycerol. /min/mg as per activity assay protocol. Storage and Stability Purity Store product at –70oC. For optimal storage, aliquot target into smaller quantities after centrifugation and store at recommended temperature. For most favorable performance, avoid repeated handling and multiple The purity of UBA1 was determined freeze/thaw cycles. to be >95% by densitometry, approx. MW 145 kDa. Scientific Background Ubiquitin-activating enzyme 1 (UBA1) catalyzes the first step in ubiquitin conjugation to mark cellular proteins for degradation through the ubiquitin-proteasome system. UBA1 activates ubiquitin by first adenylating its C-terminal glycine residue with ATP, and thereafter linking this UBA1 (UBE1), Active residue to the side chain of a cysteine residue in E1, Recombinant full-length human protein expressed in Sf9 cells yielding a ubiquitin-E1 thioester and free AMP.
    [Show full text]
  • A Systematic Analysis of Nuclear Heat Shock Protein 90 (Hsp90) Reveals A
    Max Planck Institute of Immunobiology und Epigenetics Freiburg im Breisgau A systematic analysis of nuclear Heat Shock Protein 90 (Hsp90) reveals a novel transcriptional regulatory role mediated by its interaction with Host Cell Factor-1 (HCF-1) Inaugural-Dissertation to obtain the Doctoral Degree Faculty of Biology, Albert-Ludwigs-Universität Freiburg im Breisgau presented by Aneliya Antonova born in Bulgaria Freiburg im Breisgau, Germany March 2019 Dekanin: Prof. Dr. Wolfgang Driever Promotionsvorsitzender: Prof. Dr. Andreas Hiltbrunner Betreuer der Arbeit: Referent: Dr. Ritwick Sawarkar Koreferent: Prof. Dr. Rudolf Grosschedl Drittprüfer: Prof. Dr. Andreas Hecht Datum der mündlichen Prüfung: 27.05.2019 ii AFFIDAVIT I herewith declare that I have prepared the present work without any unallowed help from third parties and without the use of any aids beyond those given. All data and concepts taken either directly or indirectly from other sources are so indicated along with a notation of the source. In particular I have not made use of any paid assistance from exchange or consulting services (doctoral degree advisors or other persons). No one has received remuneration from me either directly or indirectly for work which is related to the content of the present dissertation. The work has not been submitted in this country or abroad to any other examination board in this or similar form. The provisions of the doctoral degree examination procedure of the faculty of Biology of the University of Freiburg are known to me. In particular I am aware that before the awarding of the final doctoral degree I am not entitled to use the title of Dr.
    [Show full text]
  • The Role of Ubiquitination in NF-Κb Signaling During Virus Infection
    viruses Review The Role of Ubiquitination in NF-κB Signaling during Virus Infection Kun Song and Shitao Li * Department of Microbiology and Immunology, Tulane University, New Orleans, LA 70112, USA; [email protected] * Correspondence: [email protected] Abstract: The nuclear factor κB (NF-κB) family are the master transcription factors that control cell proliferation, apoptosis, the expression of interferons and proinflammatory factors, and viral infection. During viral infection, host innate immune system senses viral products, such as viral nucleic acids, to activate innate defense pathways, including the NF-κB signaling axis, thereby inhibiting viral infection. In these NF-κB signaling pathways, diverse types of ubiquitination have been shown to participate in different steps of the signal cascades. Recent advances find that viruses also modulate the ubiquitination in NF-κB signaling pathways to activate viral gene expression or inhibit host NF-κB activation and inflammation, thereby facilitating viral infection. Understanding the role of ubiquitination in NF-κB signaling during viral infection will advance our knowledge of regulatory mechanisms of NF-κB signaling and pave the avenue for potential antiviral therapeutics. Thus, here we systematically review the ubiquitination in NF-κB signaling, delineate how viruses modulate the NF-κB signaling via ubiquitination and discuss the potential future directions. Keywords: NF-κB; polyubiquitination; linear ubiquitination; inflammation; host defense; viral infection Citation: Song, K.; Li, S. The Role of 1. Introduction Ubiquitination in NF-κB Signaling The nuclear factor κB (NF-κB) is a small family of five transcription factors, including during Virus Infection. Viruses 2021, RelA (also known as p65), RelB, c-Rel, p50 and p52 [1].
    [Show full text]
  • SUMO and Ubiquitin in the Nucleus: Different Functions, Similar Mechanisms?
    Downloaded from genesdev.cshlp.org on September 28, 2021 - Published by Cold Spring Harbor Laboratory Press REVIEW SUMO and ubiquitin in the nucleus: different functions, similar mechanisms? Grace Gill1 Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115, USA The small ubiquitin-related modifier SUMO posttrans- tin, SUMO modification regulates protein localization lationally modifies many proteins with roles in diverse and activity. processes including regulation of transcription, chroma- This review focuses on recent advances in our under- tin structure, and DNA repair. Similar to nonproteolytic standing of SUMO function and regulation, drawing on a roles of ubiquitin, SUMO modification regulates protein limited set of examples relating to gene expression, chro- localization and activity. Some proteins can be modified matin structure, and DNA repair. Comparison of SUMO by SUMO and ubiquitin, but with distinct functional and ubiquitin activities in the nucleus reveals interest- consequences. It is possible that the effects of ubiquiti- ing differences in function and suggests surprising simi- nation and SUMOylation are both largely due to binding larities in mechanism. Thus, for example, modification of proteins bearing specific interaction domains. Both of transcription factors and histones by ubiquitin is gen- modifications are reversible, and in some cases dynamic erally associated with increased gene expression whereas cycles of modification may be required for activity. Stud- modification of transcription factors and histones by ies of SUMO and ubiquitin in the nucleus are yielding SUMO is generally associated with decreased gene ex- new insights into regulation of gene expression, genome pression. In some cases, SUMO and ubiquitin may di- maintenance, and signal transduction.
    [Show full text]
  • The Deubiquitylating Enzyme Ubp12 Regulates Rad23-Dependent Proteasomal Degradation Daniela Gödderz1, Tatiana A
    © 2017. Published by The Company of Biologists Ltd | Journal of Cell Science (2017) 130, 3336-3346 doi:10.1242/jcs.202622 RESEARCH ARTICLE The deubiquitylating enzyme Ubp12 regulates Rad23-dependent proteasomal degradation Daniela Gödderz1, Tatiana A. Giovannucci1, Jana Laláková2, Victoria Menéndez-Benito2 and Nico P. Dantuma1,* ABSTRACT et al., 2006; Richly et al., 2005; Verma et al., 2004). These proteins – The consecutive actions of the ubiquitin-selective segregase Cdc48 that share the ability to interact with ubiquitylated proteins either and the ubiquitin shuttle factor Rad23 result in the delivery of through the presence of ubiquitin-binding domains or by interacting – ubiquitylated proteins at the proteasome. Here, we show that the with proteins that contain these motifs can, depending on their deubiquitylating enzyme Ubp12 interacts with Cdc48 and regulates mode of action, either promote or prevent the degradation of proteasomal degradation of Rad23-dependent substrates in ubiquitylated proteins. Saccharomyces cerevisiae. Overexpression of Ubp12 results in In yeast, the ubiquitin-selective segregase Cdc48 [also known as stabilization of Rad23-dependent substrates. We show that Ubp12 valosin-containing protein (VCP) or p97 in mammals] is an removes short ubiquitin chains from the N-terminal ubiquitin-like interaction hub for proteins that modulate ubiquitylated proteins domain (UbL) of Rad23. Preventing ubiquitylation of Rad23 by (Jentsch and Rumpf, 2007). While the intrinsic segregase activity of mutation of lysine residues within
    [Show full text]
  • The Ubiquitin Proteasome System in Neuromuscular Disorders: Moving Beyond Movement
    International Journal of Molecular Sciences Review The Ubiquitin Proteasome System in Neuromuscular Disorders: Moving Beyond Movement 1, , 2, 3,4 Sara Bachiller * y , Isabel M. Alonso-Bellido y , Luis Miguel Real , Eva María Pérez-Villegas 5 , José Luis Venero 2 , Tomas Deierborg 1 , José Ángel Armengol 5 and Rocío Ruiz 2 1 Experimental Neuroinflammation Laboratory, Department of Experimental Medical Science, Lund University, Sölvegatan 19, 221 84 Lund, Sweden; [email protected] 2 Departamento de Bioquímica y Biología Molecular, Facultad de Farmacia, Universidad de Sevilla/Instituto de Biomedicina de Sevilla-Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, 41012 Sevilla, Spain; [email protected] (I.M.A.-B.); [email protected] (J.L.V.); [email protected] (R.R.) 3 Unidad Clínica de Enfermedades Infecciosas, Hospital Universitario de Valme, 41014 Sevilla, Spain; [email protected] 4 Departamento de Especialidades Quirúrgicas, Bioquímica e Inmunología, Facultad de Medicina, 29071 Universidad de Málaga, Spain 5 Departamento de Fisiología, Anatomía y Biología Celular, Universidad Pablo de Olavide, 41013 Sevilla, Spain; [email protected] (E.M.P.-V.); [email protected] (J.Á.A.) * Correspondence: [email protected] These authors contributed equally to the work. y Received: 14 July 2020; Accepted: 31 August 2020; Published: 3 September 2020 Abstract: Neuromuscular disorders (NMDs) affect 1 in 3000 people worldwide. There are more than 150 different types of NMDs, where the common feature is the loss of muscle strength. These disorders are classified according to their neuroanatomical location, as motor neuron diseases, peripheral nerve diseases, neuromuscular junction diseases, and muscle diseases. Over the years, numerous studies have pointed to protein homeostasis as a crucial factor in the development of these fatal diseases.
    [Show full text]